Small Animal Internal Medicine
Alejandra Lablé, DVM, MSc, PhD (c)
Veterinarian and PhD Candidate in Biomedical Engineering
Pontificia Universidad Católica de Chile
Santiago, Region Metropolitana, Chile
The fetal–neonatal transition is not merely a physiological adjustment from intrauterine to extrauterine life; it represents a critical developmental window that may shape health across the lifespan. During this period, respiratory, cardiovascular, metabolic, immunological, and microbial adaptations occur within hours to days. These early processes establish the biological baseline upon which future resilience or vulnerability is built.
Increasingly, veterinary medicine is recognizing that early-life exposures — including environmental influences, microbial colonization patterns, nutritional dynamics, inflammatory stimuli, and therapeutic interventions — may contribute to long-term programming of immune and metabolic function. Rather than viewing neonatal events as isolated episodes confined to the perinatal period, a trajectory-based framework invites us to consider how subtle perturbations during this window can influence chronic disease risk later in life.
This session will explore the conceptual bridge between transition and trajectory, examining how early physiological stressors, ecological imbalances, and developmental plasticity interact to shape systemic outcomes. Particular attention will be given to the role of early microbial establishment, immune maturation, and the delicate equilibrium between protection and overactivation. The discussion will also address how clinical decision-making in the neonatal period — especially in contexts of uncertainty — may have downstream biological implications that extend beyond immediate survival.
A critical component of this conversation involves acknowledging the diagnostic and knowledge gaps that limit our ability to fully characterize neonatal physiology and its long-term consequences. Limited reference data, nonspecific clinical indicators, and the absence of validated early biomarkers constrain our capacity to identify risk and intervene proactively. Without longitudinal frameworks and improved diagnostic tools, the link between early-life events and adult disease remains only partially understood.
By reframing neonatal medicine through a lifespan lens, this session aims to position early-life care not only as an acute clinical responsibility but also as a strategic opportunity for disease prevention. Understanding how transition shapes trajectory may redefine the way we approach feline health from birth onward.